Jaen Juan C.

President at RCUS; SVP, Drug Discovery & CSO at ChemoCentryx, Inc.

Sold, on record
$12.1M
Dollars the filings state
Form 4 sales
34
Latest Jul 10, 2026
Form 144 notices
9
Proposed sales
Companies
2
Filed as an executive or holder

Companies

Sales by reason

4
Routine
0
Plan not stated
0
No plan
1
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. 1 Form 144 notice RCUSNotice
    Dec 4, 2025 2025

    Filed to sell 82,997 shares ($2.1M)

    Jaen Juan C., Officer

    10b5-1 plan3.1x usual sizeFiling

  2. 2 Form 4 sale RCUSUnusual
    Dec 4, 2025 same day

    Sold 82,997 shares at $24.71 ($2.1M)

    Jaen Juan C., President

    10b5-1 planSold 8% of holdings ($25.6M position)954,063 shares left3.1x usual sizeFollows a Form 144Filing

  3. 3 Form 144 notice RCUSNotice
    Dec 15, 2025 +11 days

    Filed to sell 22,000 shares ($482k)

    Jaen Juan C., Officer

    10b5-1 plan0.6x usual sizeFiling

  4. 4 Form 4 sale RCUSRoutine
    Dec 17, 2025 +2 days

    Sold 21,208 shares at $22.01 ($467k)

    Jaen Juan C., President

    10b5-1 planSold 5.8% of holdings ($8.1M position)346,012 shares left0.6x usual sizeFollows a Form 144Filing

  5. 5 Form 144 notice RCUSNotice
    Jan 5, 2026 +19 days

    Filed to sell 31,823 shares ($693k)

    Jaen Juan C., Officer

    10b5-1 plan0.8x usual sizeFiling

  6. 6 Form 4 sale RCUSRoutine
    Jan 5, 2026 same day

    Sold 31,823 shares at $21.41 ($681k)

    Jaen Juan C., President

    10b5-1 planSold 3.3% of holdings ($20.4M position)922,240 shares left0.8x usual sizeFollows a Form 144Filing

  7. 7 Form 4 sale RCUSRoutine
    Jun 24, 2026 +170 days

    Sold 31,431 shares at $27.92 ($878k)

    Jaen Juan C., President

    10b5-1 planSold 3.4% of holdings ($25.7M position)890,809 shares left0.8x usual sizeFiling

  8. 8 Form 4 sale RCUSRoutine
    Jul 10, 2026 +16 days

    Sold 68,569 shares at $29.63 ($2M)

    Jaen Juan C., President

    10b5-1 planSold 7.7% of holdings ($26.4M position)822,240 shares left2.2x usual sizeFiling

Every transaction

Loading transactions…

Sales and notices (43)

Form 144 notices and Form 4 sales by Jaen Juan C.
Source
Jul 10, 2026Jul 13, 2026RCUSPresidentForm 4 sale68,569$2M7.7%RoutineSEC
Jun 24, 2026Jun 24, 2026RCUSPresidentForm 4 sale31,431$878k3.4%RoutineSEC
Jan 5, 2026Jan 7, 2026RCUSPresidentForm 4 sale31,823$681k3.3%RoutineSEC
Jan 5, 2026Jan 5, 2026RCUSOfficerForm 144 notice31,823$693kNoticeSEC
Dec 17, 2025Dec 18, 2025RCUSPresidentForm 4 sale21,208$467k5.8%RoutineSEC
Dec 15, 2025Dec 15, 2025RCUSOfficerForm 144 notice22,000$482kNoticeSEC
Dec 4, 2025Dec 5, 2025RCUSPresidentForm 4 sale82,997$2.1M8.0%UnusualSEC
Dec 4, 2025Dec 4, 2025RCUSOfficerForm 144 notice82,997$2.1MNoticeSEC
Nov 18, 2025Nov 19, 2025RCUSPresidentForm 4 sale50,000$1M4.6%RoutineSEC
Nov 17, 2025Nov 17, 2025RCUSOfficerForm 144 notice50,000$1000kNoticeSEC
Oct 30, 2025Nov 3, 2025RCUSPresidentForm 4 sale4,314$88k0.4%RoutineSEC
Oct 30, 2025Oct 30, 2025RCUSOfficerForm 144 notice1,173$24kNoticeSEC
Oct 29, 2025Oct 30, 2025RCUSPresidentForm 4 sale96,859$2M8.2%RoutineSEC
Oct 28, 2025Oct 28, 2025RCUSOfficerForm 144 notice100,000$2MNoticeSEC
Feb 27, 2024Feb 28, 2024RCUSPresidentForm 4 sale27,032$543k2.2%UnusualSEC
Jan 2, 2024Jan 4, 2024RCUSPresidentForm 4 sale6,975$140k0.6%RoutineSEC
Jan 2, 2024Jan 2, 2024RCUSOfficerForm 144 notice100,000$2MNoticeSEC
Dec 15, 2023Dec 15, 2023RCUSOfficer, DirectorForm 144 notice8,500$149kNoticeSEC
Jun 15, 2023Jun 15, 2023RCUSOfficer, DirectorForm 144 notice5,500$110kNoticeSEC
Dec 16, 2022Dec 16, 2022RCUSPresidentForm 4 sale4,436$136k2.0%Plan not statedSEC
Jun 17, 2022Jun 21, 2022RCUSPresidentForm 4 sale4,870$104k2.3%Plan not statedSEC
Dec 17, 2021Dec 20, 2021RCUSPresidentForm 4 sale1,973$79k1.0%Plan not statedSEC
Jun 17, 2021Jun 21, 2021RCUSPresidentForm 4 sale4,857$116k2.4%Plan not statedSEC
Mar 8, 2013Mar 11, 2013ChemoCentryx, Inc.SVP, Drug Discovery & CSOForm 4 sale2,795$39k8.5%Plan not statedSEC
Mar 6, 2013Mar 6, 2013ChemoCentryx, Inc.SVP, Drug Discovery & CSOForm 4 sale12,205$170k27.1%UnusualSEC
Feb 28, 2013Mar 1, 2013ChemoCentryx, Inc.SVP, Drug Discovery & CSOForm 4 sale12,599$161k21.9%UnusualSEC
Feb 26, 2013Feb 26, 2013ChemoCentryx, Inc.SVP, Drug Discovery & CSOForm 4 sale22,500$275k33.3%UnusualSEC
Feb 21, 2013Feb 21, 2013ChemoCentryx, Inc.SVP, Drug Discovery & CSOForm 4 sale22,201$264k33.0%UnusualSEC
Feb 15, 2013Feb 19, 2013ChemoCentryx, Inc.SVP, Drug Discovery & CSOForm 4 sale1,945$23k3.5%Plan not statedSEC
Feb 7, 2013Feb 8, 2013ChemoCentryx, Inc.SVP, Drug Discovery & CSOForm 4 sale1,555$18k2.9%Plan not statedSEC
Feb 4, 2013Feb 6, 2013ChemoCentryx, Inc.SVP, Drug Discovery & CSOForm 4 sale3,875$45k6.8%Plan not statedSEC
Feb 1, 2013Feb 1, 2013ChemoCentryx, Inc.SVP, Drug Discovery & CSOForm 4 sale10,005$116k15.9%Plan not statedSEC
Jan 29, 2013Jan 29, 2013ChemoCentryx, Inc.SVP, Drug Discovery & CSOForm 4 sale7,698$88k12.7%Plan not statedSEC
Jan 24, 2013Jan 24, 2013ChemoCentryx, Inc.SVP, Drug Discovery & CSOForm 4 sale1,300$15k2.4%Plan not statedSEC
Jan 12, 2013Jan 15, 2013ChemoCentryx, Inc.SVP, Drug Discovery & CSOForm 4 sale3,305$38k5.9%Plan not statedSEC
Jan 4, 2013Jan 4, 2013ChemoCentryx, Inc.SVP, Drug Discovery & CSOForm 4 sale6,017$68k10.2%Plan not statedSEC
Dec 18, 2012Dec 19, 2012ChemoCentryx, Inc.SVP, Drug Discovery & CSOForm 4 sale15,000$166k22.1%UnusualSEC
Nov 14, 2012Nov 16, 2012ChemoCentryx, Inc.SVP, Drug Discovery & CSOForm 4 sale2,000$26k3.6%Plan not statedSEC
Nov 6, 2012Nov 8, 2012ChemoCentryx, Inc.SVP, Drug Discovery & CSOForm 4 sale5,833$70k9.6%Plan not statedSEC
Oct 1, 2012Oct 1, 2012ChemoCentryx, Inc.SVP, Drug Discovery & CSOForm 4 sale2,400$29k3.8%Plan not statedSEC
Sep 25, 2012Sep 27, 2012ChemoCentryx, Inc.SVP, Drug Discovery & CSOForm 4 sale7,401$89k10.5%Plan not statedSEC
Sep 24, 2012Sep 24, 2012ChemoCentryx, Inc.SVP, Drug Discovery & CSOForm 4 sale3,566$43k4.8%Plan not statedSEC
Sep 17, 2012Sep 19, 2012ChemoCentryx, Inc.SVP, Drug Discovery & CSOForm 4 sale800$10k1.1%Plan not statedSEC